-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SGD0Gpa4t4qLi/nYOqjwqBvYTtCPcVfe9Tf7YjnveRD9THKfcXZGlnEbm7zMNYtP P0sSGi8/j3Z1T7vXT6x34A== 0000950103-04-000389.txt : 20040316 0000950103-04-000389.hdr.sgml : 20040316 20040316171342 ACCESSION NUMBER: 0000950103-04-000389 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040312 FILED AS OF DATE: 20040316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENENTECH INC CENTRAL INDEX KEY: 0000318771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942347624 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-225-1000 MAIL ADDRESS: STREET 1: 1 DNA WAY STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROCHE HOLDINGS INC CENTRAL INDEX KEY: 0000904566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09813 FILM NUMBER: 04673448 BUSINESS ADDRESS: STREET 1: 1201 NORTH ORANGE STREET STREET 2: SUITE #1050 CITY: WILMINGTON STATE: DE ZIP: 19801-1184 BUSINESS PHONE: 302 425 4701 MAIL ADDRESS: STREET 1: 1201 NORTH ORANGE STREET STREET 2: SUITE #1050 CITY: WILMINGTON STATE: DE ZIP: 19801-1184 4 1 mar1604_form4ex.xml X0201 4 2004-03-12 0 0000318771 GENENTECH INC DNA 0000904566 ROCHE HOLDINGS INC 1201 NORTH ORANGE STREET WILMINGTON DE 19801 0 0 1 0 Common Stock 2004-03-12 4 C 0 739842 0 D 300444147 D Common Stock 2004-03-15 4 C 0 599965 0 D 299844182 D Liquid Yield Option Notes 0 2004-03-12 4 C 0 0 0 D 2000-01-19 2015-01-19 Common Stock 8.653 795504000 D Liquid Yield Option Notes 0 2004-03-15 4 C 0 0 0 D 2000-01-19 2015-01-19 Common Stock 8.653 726169000 D Each $1,000 principal amount of Liquid Yield Option (TM) Notes is exchangeable into 8.65316 shares. On 03/12/2004, the reporting person settled $85,500,000 in principal amount of Liquid Yield Option (TM) Notes. In settlement of such notes, the reporting person delivered 739,842 Genentech shares and $337.16 to the holders of such notes. Issue date In dollar amounts On 03/15/2004, the reporting person settled $69,335,000 in principal amount of Liquid Yield Option (TM) Notes. In settlement of such notes, the reporting person delivered 599,965 Genentech shares and $199.09 to the holders of such notes. /s/ Carol Fiederlein, Vice President, Tax and Accounting and Corporate Secretary 2004-03-16 -----END PRIVACY-ENHANCED MESSAGE-----